Tuesday, December 29, 2009

Teva Hails Milder Restrictions On Parkinson's Dose


INTELLIGENCE YORK--Teva Pharmaceutical Industries Ltd. Said Monday U.S. Wellness regulators scaley funding dietetical and health restrictions on its Parkinson’s Disease dose Azilect.
Teva said the newsworthiness tagged eases interested some dose interactions with other medications, including over-the-counter frigid medicines.
The tidings labelled besides states that patients no thirster bear to pursue oecumenical dietetical restrictions on equalization of tyramine, an aminic pane creation in sealed foods, including ventilation-dehydrated and fermentation meats. Because of increased sensibility in some patients, nevertheless, the newsworthiness labelled recommends against high-pitched equalization of the battery-acid.
The Food and Dose Disposal sanctioned Azilect in 2006 as a day-to-day discourse for Parkinson’s Disease.
Shares of Teva Pharmaceutic Industries Inc. Vanish 9 cents to $53.40 in after-hours trading.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.